Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04495049 · ClinicalTrials.gov registry record
Vivity Insight: A Study of Patient Satisfaction and Visual Performance
A clinical trial, sponsored by Research Insight.
- Completed
- Registry status
- 60
- Enrollment target
NCT04495049: Completed study, sponsored by Research Insight.
NCT04495049 is a clinical trial that has completed, run by Research Insight. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04495049 has completed, sponsored by Research Insight.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This will be a single arm, open-label, prospective study of patient-reported outcomes of patients with bilateral implantation of the Vivity or Vivity Toric implant.
Primary Outcome
Percentage of patients reporting "not at all" or "just a little" when asked, "With or without glasses, how much do you notice glare or haloes around lights in dim light situations?"
Interventions
- DEVICE Alcon Vivity or Vivity Toric IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2021-04-30 |
What the finished NCT04495049 record still lists
NCT04495049 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Alcon Vivity or Vivity Toric IOL is the first listed.
NCT04495049 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04495049 about?
NCT04495049 is a clinical study titled "Vivity Insight: A Study of Patient Satisfaction and Visual Performance". This will be a single arm, open-label, prospective study of patient-reported outcomes of patients with bilateral implantation of the Vivity or Vivity Toric implant.
What is the current status of trial NCT04495049?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2020-08-01. Estimated completion is 2021-04-30.
What interventions are being tested in trial NCT04495049?
The interventions under investigation include: Alcon Vivity or Vivity Toric IOL (DEVICE).
Who is sponsoring clinical trial NCT04495049?
This trial is sponsored by Research Insight, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI